Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0155339 (
Brown
)
12,436
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
1. The influence of halogen substituents on the 1,2-dioxygenation of catechols was investigated. The results obtained with the two isoenzymes
pyrocatechase
I and
pyrocatechase
II from the haloarene-utilizing Pseudomonas sp. B 13 and the
pyrocatechase
from benzoate-induced cells of Alcaligenes eutrophus B.9 were compared. 2. Substituents on catechol were found to interfere with O2 binding by the two isoenzymes from Pseudomonas sp. B 13, whereas the Km value for catechol kept constant at different O2 concentrations. 3. Electron-attracting substituents decreased the Km values for catechols. 4. Results from binding studies with substituted catechols demonstrated narrow stereospecificities of
pyrocatechase
I from pseudomonas sp. B 13 and the
pyrocatechase
from alcaligenes eutrophus B.9. In contrast, a low steric hindrance by substituents in the binding of catechols with
pyrocatechase
II was observed. 5. Low pK'1 values of substituted catechols resulted in low Michaelis constants. 6. Electron-attracting substituents such as halogen decreased the reaction rates of catechol 1,2-dioxygenation. The correlation of the Vmax. values observed with
pyrocatechase
II from Pseudomonas sp. B 13 with the substituent constant sigma+ (Okamoto--
Brown
equation) was distinctly greater than with Hammett's sigma values. The corresponding logVmax. against sigma+ correlation for
pyrocatechase
I was considerably disturbed by steric influences of the substituents.
...
PMID:Chemical structure and biodegradability of halogenated aromatic compounds. Substituent effects on 1,2-dioxygenation of catechol. 69 66